Journal Article
. 2010 Feb; 207(3):651-67.
doi: 10.1084/jem.20091921.

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma

Ying Xie 1 Akgül Akpinarli  Charles Maris  Edward L Hipkiss  Malcolm Lane  Eun-Kyung M Kwon  Pawel Muranski  Nicholas P Restifo  Paul Andrew Antony  
Affiliations
  • PMID: 20156973
  •     86 References
  •     216 citations

Abstract

In vitro differentiated CD8(+) T cells have been the primary focus of immunotherapy of cancer with little focus on CD4(+) T cells. Immunotherapy involving in vitro differentiated T cells given after lymphodepleting regimens significantly augments antitumor immunity in animals and human patients with cancer. However, the mechanisms by which lymphopenia augments adoptive cell therapy and the means of properly differentiating T cells in vitro are still emerging. We demonstrate that naive tumor/self-specific CD4(+) T cells naturally differentiated into T helper type 1 cytotoxic T cells in vivo and caused the regression of established tumors and depigmentation in lymphopenic hosts. Therapy was independent of vaccination, exogenous cytokine support, CD8(+), B, natural killer (NK), and NKT cells. Proper activation of CD4(+) T cells in vivo was important for tumor clearance, as naive tumor-specific CD4(+) T cells could not completely treat tumor in lymphopenic common gamma chain (gamma(c))-deficient hosts. gamma(c) signaling in the tumor-bearing host was important for survival and proper differentiation of adoptively transferred tumor-specific CD4(+) T cells. Thus, these data provide a platform for designing immunotherapies that incorporate tumor/self-reactive CD4(+) T cells.

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
L Diehl, A T den Boer, +5 authors, R E Toes.
Nat Med, 1999 Jul 08; 5(7). PMID: 10395322
Highly Cited.
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
Hua Zhang, Kevin S Chua, +12 authors, Crystal L Mackall.
Nat Med, 2005 Oct 18; 11(11). PMID: 16227988
Highly Cited.
The central role of CD4(+) T cells in the antitumor immune response.
K Hung, R Hayashi, +3 authors, H Levitsky.
J Exp Med, 1998 Dec 22; 188(12). PMID: 9858522    Free PMC article.
Highly Cited.
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.
Claudia Wrzesinski, Chrystal M Paulos, +5 authors, Nicholas P Restifo.
J Clin Invest, 2007 Feb 03; 117(2). PMID: 17273561    Free PMC article.
IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Peter Dubsky, Hiroaki Saito, +4 authors, A Karolina Palucka.
Eur J Immunol, 2007 May 12; 37(6). PMID: 17492620
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.
Christopher A Klebanoff, Luca Gattinoni, +9 authors, Nicholas P Restifo.
Proc Natl Acad Sci U S A, 2005 Jun 28; 102(27). PMID: 15980149    Free PMC article.
Highly Cited.
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.
Luca Gattinoni, Christopher A Klebanoff, +7 authors, Nicholas P Restifo.
J Clin Invest, 2005 Jun 03; 115(6). PMID: 15931392    Free PMC article.
Highly Cited.
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
Mark P Rubinstein, Marek Kovar, +4 authors, Jonathan Sprent.
Proc Natl Acad Sci U S A, 2006 Jun 08; 103(24). PMID: 16757567    Free PMC article.
Highly Cited.
CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.
Z Qin, T Blankenstein.
Immunity, 2000 Jul 14; 12(6). PMID: 10894167
Highly Cited.
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
Luca Gattinoni, Steven E Finkelstein, +10 authors, Nicholas P Restifo.
J Exp Med, 2005 Oct 06; 202(7). PMID: 16203864    Free PMC article.
Highly Cited.
Genomic anatomy of the Tyrp1 (brown) deletion complex.
Ian M Smyth, Laurens Wilming, +57 authors, Ian J Jackson.
Proc Natl Acad Sci U S A, 2006 Mar 01; 103(10). PMID: 16505357    Free PMC article.
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection.
Matthias T Stephan, Vladimir Ponomarev, +4 authors, Michel Sadelain.
Nat Med, 2007 Nov 21; 13(12). PMID: 18026115
Highly Cited.
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
Mark E Dudley, John R Wunderlich, +16 authors, Steven A Rosenberg.
Science, 2002 Sep 21; 298(5594). PMID: 12242449    Free PMC article.
Highly Cited.
Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells.
Magali Terme, Nathalie Chaput, +3 authors, Laurence Zitvogel.
J Immunol, 2008 Mar 21; 180(7). PMID: 18354191
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Mark E Dudley, John R Wunderlich, +18 authors, Steven A Rosenberg.
J Clin Oncol, 2005 Apr 01; 23(10). PMID: 15800326    Free PMC article.
Highly Cited.
Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.
A D Luster, J C Unkeless, J V Ravetch.
Nature, 1985 Jun 20; 315(6021). PMID: 3925348
Highly Cited.
Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
S R Bennett, F R Carbone, +3 authors, W R Heath.
Nature, 1998 Jun 12; 393(6684). PMID: 9624004
Highly Cited.
De novo HLA class II and enhanced HLA class I molecule expression in SV40 transfected human thyroid epithelial cells.
A Belfiore, T Mauerhoff, +4 authors, G F Bottazzo.
J Autoimmun, 1991 Jun 01; 4(3). PMID: 1654916
Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.
Christopher A Klebanoff, Zhiya Yu, +3 authors, Nicholas P Restifo.
Blood, 2009 Jun 30; 114(9). PMID: 19561320    Free PMC article.
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
Martin A Pule, Barbara Savoldo, +13 authors, Malcolm K Brenner.
Nat Med, 2008 Nov 04; 14(11). PMID: 18978797    Free PMC article.
Highly Cited.
Taming cancer by inducing immunity via dendritic cells.
A Karolina Palucka, Hideki Ueno, Joseph W Fay, Jacques Banchereau.
Immunol Rev, 2007 Nov 06; 220. PMID: 17979844
Review.
Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo.
Toshiaki Ohteki, Hiroyuki Tada, +5 authors, Shigeo Koyasu.
J Exp Med, 2006 Sep 13; 203(10). PMID: 16966429    Free PMC article.
CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection.
Todd Wuest, Joshua Farber, Andrew Luster, Daniel J J Carr.
Cell Immunol, 2007 Feb 14; 243(2). PMID: 17296171    Free PMC article.
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.
Matthew A Williams, Aaron J Tyznik, Michael J Bevan.
Nature, 2006 Jun 17; 441(7095). PMID: 16778891    Free PMC article.
Highly Cited.
Adoptive cell transfer: a clinical path to effective cancer immunotherapy.
Steven A Rosenberg, Nicholas P Restifo, +2 authors, Mark E Dudley.
Nat Rev Cancer, 2008 Mar 21; 8(4). PMID: 18354418    Free PMC article.
Highly Cited. Review.
Editorial overview: lymphocyte development.
Casey T Weaver, Alexander Y Rudensky.
Curr Opin Immunol, 2009 Apr 14; 21(2). PMID: 19361970
CD4 cells can be more efficient at tumor rejection than CD8 cells.
Ainhoa Perez-Diez, Nathalie T Joncker, +4 authors, Polly Matzinger.
Blood, 2007 Mar 01; 109(12). PMID: 17327412    Free PMC article.
Highly Cited.
Harnessing human dendritic cell subsets to design novel vaccines.
Jacques Banchereau, Eynav Klechevsky, +3 authors, Hideki Ueno.
Ann N Y Acad Sci, 2009 Sep 23; 1174. PMID: 19769733    Free PMC article.
Review.
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.
R P Sutmuller, L M van Duivenvoorde, +6 authors, C J Melief.
J Exp Med, 2001 Sep 19; 194(6). PMID: 11560997    Free PMC article.
Highly Cited.
TCR-MHC class II interaction is required for peripheral expansion of CD4 cells in a T cell-deficient host.
U Beutner, H R MacDonald.
Int Immunol, 1998 May 12; 10(3). PMID: 9576618
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.
J P Ridge, F Di Rosa, P Matzinger.
Nature, 1998 Jun 12; 393(6684). PMID: 9624003
Highly Cited.
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells.
Luca Gattinoni, Xiao-Song Zhong, +10 authors, Nicholas P Restifo.
Nat Med, 2009 Jun 16; 15(7). PMID: 19525962    Free PMC article.
Highly Cited.
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.
Martin Guimond, Rachelle G Veenstra, +11 authors, Crystal L Mackall.
Nat Immunol, 2009 Jan 13; 10(2). PMID: 19136960    Free PMC article.
Highly Cited.
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity.
Douglas C Palmer, Chi-Chao Chan, +11 authors, Nicholas P Restifo.
Proc Natl Acad Sci U S A, 2008 Jun 05; 105(23). PMID: 18523011    Free PMC article.
Priming of naive T cells inside tumors leads to eradication of established tumors.
Ping Yu, Youjin Lee, +7 authors, Yang-Xin Fu.
Nat Immunol, 2004 Jan 06; 5(2). PMID: 14704792
Highly Cited.
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
Laura A Johnson, Richard A Morgan, +22 authors, Steven A Rosenberg.
Blood, 2009 May 20; 114(3). PMID: 19451549    Free PMC article.
Highly Cited.
Primary antitumor immune response mediated by CD4+ T cells.
Alexandre Corthay, Dag K Skovseth, +5 authors, Bjarne Bogen.
Immunity, 2005 Mar 23; 22(3). PMID: 15780993
Highly Cited.
Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.
T Nishimura, K Iwakabe, +8 authors, A Ohta.
J Exp Med, 1999 Sep 08; 190(5). PMID: 10477547    Free PMC article.
The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.
S A Kalams, B D Walker.
J Exp Med, 1998 Dec 22; 188(12). PMID: 9858506    Free PMC article.
Highly Cited. Review.
Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells.
George Kassiotis, Rose Zamoyska, Brigitta Stockinger.
J Exp Med, 2003 Apr 23; 197(8). PMID: 12707300    Free PMC article.
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity.
R F Wang.
Trends Immunol, 2001 Apr 27; 22(5). PMID: 11323286
Review.
High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction.
Andrew G Brandmaier, Wolfgang W Leitner, +3 authors, Christopher E Touloukian.
J Immunother, 2009 Jun 30; 32(7). PMID: 19561540    Free PMC article.
Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.
William Y Ho, Cassian Yee, Philip D Greenberg.
J Clin Invest, 2002 Nov 20; 110(10). PMID: 12438439    Free PMC article.
Review.
Adoptive immunotherapy for cancer: building on success.
Luca Gattinoni, Daniel J Powell, Steven A Rosenberg, Nicholas P Restifo.
Nat Rev Immunol, 2006 Apr 20; 6(5). PMID: 16622476    Free PMC article.
Highly Cited. Review.
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.
Sergio A Quezada, Karl S Peggs, +3 authors, James P Allison.
J Exp Med, 2008 Aug 30; 205(9). PMID: 18725522    Free PMC article.
Highly Cited.
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.
D Mumberg, P A Monach, +4 authors, H Schreiber.
Proc Natl Acad Sci U S A, 1999 Jul 21; 96(15). PMID: 10411927    Free PMC article.
Highly Cited.
Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.
Alfonso Martín-Fontecha, Lindy L Thomsen, +4 authors, Federica Sallusto.
Nat Immunol, 2004 Nov 09; 5(12). PMID: 15531883
Highly Cited.
Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response.
T Ohteki, K Suzue, +2 authors, S Koyasu.
Nat Immunol, 2001 Nov 10; 2(12). PMID: 11702064
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.
Luis Vence, A Karolina Palucka, +4 authors, Hideki Ueno.
Proc Natl Acad Sci U S A, 2007 Dec 21; 104(52). PMID: 18093940    Free PMC article.
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.
Chrystal M Paulos, Claudia Wrzesinski, +11 authors, Nicholas P Restifo.
J Clin Invest, 2007 Jul 28; 117(8). PMID: 17657310    Free PMC article.
Highly Cited.
Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules.
Koji Tamada, Lieping Chen.
Cancer Immunol Immunother, 2005 Sep 28; 55(4). PMID: 16187084
Review.
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
Julia Menke, Geraldine C Zeller, +7 authors, Vicki R Kelley.
J Am Soc Nephrol, 2008 Mar 14; 19(6). PMID: 18337479    Free PMC article.
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
Jeong M Kim, Jeffrey P Rasmussen, Alexander Y Rudensky.
Nat Immunol, 2006 Dec 01; 8(2). PMID: 17136045
Highly Cited.
CD4 T cells and their role in antitumor immune responses.
R E Toes, F Ossendorp, R Offringa, C J Melief.
J Exp Med, 1999 Mar 02; 189(5). PMID: 10049938    Free PMC article.
Highly Cited.
Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
Onur Boyman, Marek Kovar, +2 authors, Jonathan Sprent.
Science, 2006 Feb 18; 311(5769). PMID: 16484453
Highly Cited.
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.
X Cao, E W Shores, +7 authors, E T Bloom.
Immunity, 1995 Mar 01; 2(3). PMID: 7697543
Highly Cited.
Tumor-specific Th17-polarized cells eradicate large established melanoma.
Pawel Muranski, Andrea Boni, +14 authors, Nicholas P Restifo.
Blood, 2008 Mar 21; 112(2). PMID: 18354038    Free PMC article.
Highly Cited.
Helper T cells, dendritic cells and CTL Immunity.
Georg Behrens, Ming Li, +4 authors, William R Heath.
Immunol Cell Biol, 2004 Feb 27; 82(1). PMID: 14984599
Review.
An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2.
Jae-Ho Cho, Onur Boyman, +6 authors, Jonathan Sprent.
J Exp Med, 2007 Aug 01; 204(8). PMID: 17664294    Free PMC article.
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.
E M Sotomayor, I Borrello, +6 authors, H I Levitsky.
Nat Med, 1999 Jul 08; 5(7). PMID: 10395323
Highly Cited.
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.
Willem W Overwijk, Marc R Theoret, +15 authors, Nicholas P Restifo.
J Exp Med, 2003 Aug 20; 198(4). PMID: 12925674    Free PMC article.
Highly Cited.
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
Sergio A Quezada, Karl S Peggs, Michael A Curran, James P Allison.
J Clin Invest, 2006 Jun 17; 116(7). PMID: 16778987    Free PMC article.
Highly Cited.
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
Paul A Antony, Chrystal M Paulos, +9 authors, Nicholas P Restifo.
J Immunol, 2006 Apr 20; 176(9). PMID: 16621991    Free PMC article.
IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia.
Onur Boyman, Chris Ramsey, +2 authors, Charles D Surh.
J Immunol, 2008 May 21; 180(11). PMID: 18490726
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.
Sergio A Quezada, Tyler R Simpson, +9 authors, James P Allison.
J Exp Med, 2010 Feb 17; 207(3). PMID: 20156971    Free PMC article.
Highly Cited.
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies.
Marc Pellegrini, Thomas Calzascia, +12 authors, Tak W Mak.
Nat Med, 2009 Apr 28; 15(5). PMID: 19396174
Progress in human tumour immunology and immunotherapy.
S A Rosenberg.
Nature, 2001 May 18; 411(6835). PMID: 11357146
Highly Cited. Review.
Helper requirements for generation of effector CTL to islet beta cell antigens.
Georg M N Behrens, Ming Li, +4 authors, William R Heath.
J Immunol, 2004 Apr 22; 172(9). PMID: 15100283
CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen.
M Kahn, H Sugawara, +5 authors, P Greenberg.
J Immunol, 1991 May 01; 146(9). PMID: 1707934
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.
A L Marzo, B F Kinnear, +4 authors, B Scott.
J Immunol, 2000 Nov 22; 165(11). PMID: 11086036
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.
Edith M Janssen, Edward E Lemmens, +3 authors, Stephen P Schoenberger.
Nature, 2003 Feb 21; 421(6925). PMID: 12594515
Highly Cited.
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.
Karl S Peggs, Sergio A Quezada, +2 authors, James P Allison.
J Exp Med, 2009 Jul 08; 206(8). PMID: 19581407    Free PMC article.
Highly Cited.
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.
Ryan A Wilcox, Dallas B Flies, +6 authors, Lieping Chen.
J Clin Invest, 2002 Mar 06; 109(5). PMID: 11877473    Free PMC article.
Cancer regression in patients after transfer of genetically engineered lymphocytes.
Richard A Morgan, Mark E Dudley, +13 authors, Steven A Rosenberg.
Science, 2006 Sep 02; 314(5796). PMID: 16946036    Free PMC article.
Highly Cited.
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.
James O McNamara, Despina Kolonias, +5 authors, Eli Gilboa.
J Clin Invest, 2007 Dec 07; 118(1). PMID: 18060045    Free PMC article.
Highly Cited.
Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses.
Hideki Nakano, Kaifeng Lisa Lin, +4 authors, Michael D Gunn.
Nat Immunol, 2009 Mar 03; 10(4). PMID: 19252492    Free PMC article.
Highly Cited.
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.
Christian S Hinrichs, Zachary A Borman, +14 authors, Nicholas P Restifo.
Proc Natl Acad Sci U S A, 2009 Oct 07; 106(41). PMID: 19805141    Free PMC article.
Highly Cited.
Taking dendritic cells into medicine.
Ralph M Steinman, Jacques Banchereau.
Nature, 2007 Sep 28; 449(7161). PMID: 17898760
Highly Cited. Review.
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
Mark E Dudley, James C Yang, +17 authors, Steven A Rosenberg.
J Clin Oncol, 2008 Sep 24; 26(32). PMID: 18809613    Free PMC article.
Highly Cited.
Adoptive immunotherapy of cancer using CD4(+) T cells.
Pawel Muranski, Nicholas P Restifo.
Curr Opin Immunol, 2009 Mar 17; 21(2). PMID: 19285848    Free PMC article.
Highly Cited. Review.
Oncogenic stress sensed by the immune system: role of natural killer cell receptors.
David H Raulet, Nadia Guerra.
Nat Rev Immunol, 2009 Jul 25; 9(8). PMID: 19629084    Free PMC article.
Highly Cited. Review.
Immune therapy for cancer.
Michael Dougan, Glenn Dranoff.
Annu Rev Immunol, 2008 Nov 15; 27. PMID: 19007331
Highly Cited. Review.
Autoimmunity and tumor immunity induced by immune responses to mutations in self.
Manuel E Engelhorn, José A Guevara-Patiño, +5 authors, Alan N Houghton.
Nat Med, 2006 Jan 31; 12(2). PMID: 16444264
Further checkpoints in Th1 development.
Douglas S Robinson, Anne O'Garra.
Immunity, 2002 Jul 18; 16(6). PMID: 12121657
Review.
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.
Paul A Antony, Ciriaco A Piccirillo, +9 authors, Nicholas P Restifo.
J Immunol, 2005 Feb 25; 174(5). PMID: 15728465    Free PMC article.
Highly Cited.
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.
Naomi N Hunder, Herschel Wallen, +7 authors, Cassian Yee.
N Engl J Med, 2008 Jun 21; 358(25). PMID: 18565862    Free PMC article.
Highly Cited.
CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.
Yolanda C Nesbeth, Diana G Martinez, +4 authors, Jose R Conejo-Garcia.
J Immunol, 2010 Apr 20; 184(10). PMID: 20400704    Free PMC article.
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase.
Timothy L Frankel, William R Burns, +7 authors, Richard A Morgan.
J Immunol, 2010 Apr 30; 184(11). PMID: 20427771    Free PMC article.
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer.
Maciej Kmieciak, Andrea Worschech, +8 authors, Masoud H Manjili.
Breast Cancer Res Treat, 2010 May 19; 126(2). PMID: 20480224    Free PMC article.
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Swagatam Ray, Arvind Chhabra, +11 authors, UCLA-CALTECH-CHLA-USC-UCONN Consortium on Translational Program in Engineered Immunity.
Clin Immunol, 2010 Jun 16; 136(3). PMID: 20547105    Free PMC article.
The polarization of immune cells in the tumour environment by TGFbeta.
Richard A Flavell, Shomyseh Sanjabi, Stephen H Wrzesinski, Paula Licona-Limón.
Nat Rev Immunol, 2010 Jul 10; 10(8). PMID: 20616810    Free PMC article.
Highly Cited. Review.
Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytes.
Claude Carnaud, Véronique Bachy.
Prion, 2010 Jul 14; 4(2). PMID: 20622507    Free PMC article.
GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
Matthew P Rausch, Kari R Irvine, +3 authors, K Taraszka Hastings.
J Immunol, 2010 Jul 30; 185(5). PMID: 20668223    Free PMC article.
Dendritic cells: are they clinically relevant?
Karolina Palucka, Hideki Ueno, +2 authors, Jacques Banchereau.
Cancer J, 2010 Aug 10; 16(4). PMID: 20693842    Free PMC article.
Review.
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.
Natko Nuber, Alessandra Curioni-Fontecedro, +7 authors, Maries van den Broek.
Proc Natl Acad Sci U S A, 2010 Aug 11; 107(34). PMID: 20696919    Free PMC article.
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.
Matthew J Goldstein, Bindu Varghese, +5 authors, Ronald Levy.
Blood, 2010 Sep 30; 117(1). PMID: 20876455    Free PMC article.
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.
Christian S Hinrichs, Zachary A Borman, +14 authors, Nicholas P Restifo.
Blood, 2010 Oct 26; 117(3). PMID: 20971955    Free PMC article.
Highly Cited.
Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.
Yolanda Nesbeth, Jose R Conejo-Garcia.
Clin Dev Immunol, 2010 Nov 16; 2010. PMID: 21076522    Free PMC article.
Review.
Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.
Sung P Ha, Nicholas D Klemen, +8 authors, Christopher E Touloukian.
J Clin Invest, 2010 Nov 19; 120(12). PMID: 21084750    Free PMC article.
Impact of γ-chain cytokines on EBV-specific T cell cultures.
Anna Merlo, Riccardo Turrini, +3 authors, Antonio Rosato.
J Transl Med, 2010 Nov 26; 8. PMID: 21092174    Free PMC article.
Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries.
Wolfram Osen, Sabine Soltek, +7 authors, Annette Paschen.
PLoS One, 2010 Dec 15; 5(11). PMID: 21152437    Free PMC article.
Dendritic cells and immunity against cancer.
K Palucka, H Ueno, J Fay, J Banchereau.
J Intern Med, 2010 Dec 17; 269(1). PMID: 21158979    Free PMC article.
Review.
Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.
Tong Zhang, Charles L Sentman.
Cancer Res, 2011 Feb 02; 71(6). PMID: 21282338    Free PMC article.
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes.
Else M Inderberg Suso, Svein Dueland, +4 authors, Gustav Gaudernack.
Cancer Immunol Immunother, 2011 Mar 03; 60(6). PMID: 21365467    Free PMC article.
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.
Sergio A Quezada, Karl S Peggs, Tyler R Simpson, James P Allison.
Immunol Rev, 2011 Apr 15; 241(1). PMID: 21488893    Free PMC article.
Highly Cited. Review.
MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure.
Andrew J Erie, Leigh Samsel, +5 authors, Jichun Chen.
Exp Hematol, 2011 Jun 04; 39(8). PMID: 21635935    Free PMC article.
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.
Moses K Donkor, Abira Sarkar, +5 authors, Ming O Li.
Immunity, 2011 Jul 16; 35(1). PMID: 21757379    Free PMC article.
Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations.
Zhaoting Meng, Yadong Wang, +8 authors, Shunchang Jiao.
J Immunother, 2011 Jul 16; 34(7). PMID: 21760531    Free PMC article.
Selective expansion and enhanced anti-tumor effect of antigen-specific CD4(+) T cells by retrovirus-mediated IL-15 expression.
Jizhou Lv, Ning Tao, +4 authors, Zhihai Qin.
Protein Cell, 2011 Aug 09; 2(7). PMID: 21822803    Free PMC article.
GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1.
Matthew P Rausch, K Taraszka Hastings.
J Invest Dermatol, 2011 Aug 13; 132(1). PMID: 21833020    Free PMC article.
Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory.
Jang-June Park, Sudarshan Anand, +6 authors, Koji Tamada.
Cancer Immunol Immunother, 2011 Aug 31; 61(2). PMID: 21877247    Free PMC article.
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.
Harry Z Qui, Adam T Hagymasi, +8 authors, Adam J Adler.
J Immunol, 2011 Sep 02; 187(7). PMID: 21880986    Free PMC article.
New perspectives on the role of vitiligo in immune responses to melanoma.
Katelyn T Byrne, Mary Jo Turk.
Oncotarget, 2011 Sep 14; 2(9). PMID: 21911918    Free PMC article.
Review.
Experimental mouse tumour models: what can be learnt about human cancer immunology?
Glenn Dranoff.
Nat Rev Immunol, 2011 Dec 03; 12(1). PMID: 22134155
Review.
Cytotoxic CD4 T cells in antiviral immunity.
Nikki B Marshall, Susan L Swain.
J Biomed Biotechnol, 2011 Dec 17; 2011. PMID: 22174559    Free PMC article.
Review.
Th17 cells are long lived and retain a stem cell-like molecular signature.
Pawel Muranski, Zachary A Borman, +19 authors, Nicholas P Restifo.
Immunity, 2011 Dec 20; 35(6). PMID: 22177921    Free PMC article.
Highly Cited.
Development of a DNA vaccine targeting Merkel cell polyomavirus.
Qi Zeng, Bianca P Gomez, +5 authors, Chien-Fu Hung.
Vaccine, 2012 Jan 03; 30(7). PMID: 22210138    Free PMC article.
Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells.
Matthew J Goldstein, Holbrook E Kohrt, +4 authors, Ronald Levy.
Cancer Res, 2012 Jan 11; 72(5). PMID: 22232735    Free PMC article.
Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells.
Y Gao, P Whitaker-Dowling, J A Griffin, I Bergman.
Cancer Gene Ther, 2012 Jan 14; 19(4). PMID: 22240921    Free PMC article.
Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.
Arya Biragyn, Dan L Longo.
Semin Cancer Biol, 2012 Jan 20; 22(1). PMID: 22257681    Free PMC article.
Review.
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma.
Caroline J Voskens, Duane Sewell, +15 authors, Scott E Strome.
Head Neck, 2012 Jan 31; 34(12). PMID: 22287423    Free PMC article.
Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81.
Yael Sagi, Angela Landrigan, Ronald Levy, Shoshana Levy.
Proc Natl Acad Sci U S A, 2012 Feb 07; 109(5). PMID: 22307619    Free PMC article.
Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation.
Justin Kline, Long Zhang, +2 authors, Thomas F Gajewski.
J Immunol, 2012 Feb 09; 188(6). PMID: 22312128    Free PMC article.
Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus.
Olivier Moralès, Audrey Richard, +8 authors, Nadira Delhem.
PLoS One, 2012 Feb 24; 7(2). PMID: 22359669    Free PMC article.
Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
Bei Wang, Neeha Zaidi, +4 authors, Ralph M Steinman.
Breast Cancer Res, 2012 Mar 09; 14(2). PMID: 22397502    Free PMC article.
Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.
Zhi-Chun Ding, Gang Zhou.
Clin Dev Immunol, 2012 Mar 09; 2012. PMID: 22400040    Free PMC article.
Review.
Adoptive immunotherapy for cancer: harnessing the T cell response.
Nicholas P Restifo, Mark E Dudley, Steven A Rosenberg.
Nat Rev Immunol, 2012 Mar 23; 12(4). PMID: 22437939    Free PMC article.
Highly Cited. Review.
Immunoglobulin Fc fragment tagging allows strong activation of endogenous CD4 T cells to reshape the tumor milieu and enhance the antitumor effect of lentivector immunization.
Yuan Hong, Yibing Peng, +3 authors, Yukai He.
J Immunol, 2012 Apr 17; 188(10). PMID: 22504640    Free PMC article.
Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.
Dalya R Soond, Fabien Garçon, +5 authors, Klaus Okkenhaug.
J Immunol, 2012 May 23; 188(12). PMID: 22611241    Free PMC article.
A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth.
Frank T Wen, Ronald A Thisted, Donald A Rowley, Hans Schreiber.
Oncoimmunology, 2012 Jun 22; 1(2). PMID: 22720238    Free PMC article.
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.
Shawn M Jensen, Christopher G Twitty, +6 authors, Bernard A Fox.
J Immunol, 2012 Jun 23; 189(2). PMID: 22723522    Free PMC article.
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.
Rahul Purwar, Christoph Schlapbach, +9 authors, Thomas S Kupper.
Nat Med, 2012 Jul 10; 18(8). PMID: 22772464    Free PMC article.
Highly Cited.
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.
Shikhar Mehrotra, Amir A Al-Khami, +15 authors, Michael I Nishimura.
J Immunol, 2012 Jul 17; 189(4). PMID: 22798675    Free PMC article.
NFAT1 supports tumor-induced anergy of CD4(+) T cells.
Brian T Abe, Daniel S Shin, Enric Mocholi, Fernando Macian.
Cancer Res, 2012 Aug 07; 72(18). PMID: 22865456    Free PMC article.
MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.
Caroline Poli, Caroline Raffin, +3 authors, Danila Valmori.
Haematologica, 2012 Aug 10; 98(2). PMID: 22875619    Free PMC article.
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.
Carolina M Soto, Jennifer D Stone, +4 authors, David M Kranz.
Cancer Immunol Immunother, 2012 Aug 29; 62(2). PMID: 22926060    Free PMC article.
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001.
Else-Marit Inderberg-Suso, Sissel Trachsel, +2 authors, Gustav Gaudernack.
Oncoimmunology, 2012 Aug 31; 1(5). PMID: 22934259    Free PMC article.
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.
Daniel Hirschhorn-Cymerman, Sadna Budhu, +10 authors, Jedd D Wolchok.
J Exp Med, 2012 Sep 26; 209(11). PMID: 23008334    Free PMC article.
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity.
Luise U Weigand, Xiaoling Liang, +8 authors, Angela M Krackhardt.
Immunology, 2012 Oct 03; 137(3). PMID: 23025755    Free PMC article.
Anti-tumor immunity: myeloid leukocytes control the immune landscape.
Melanie R Rutkowski, Tom L Stephen, Jose R Conejo-Garcia.
Cell Immunol, 2012 Nov 06; 278(1-2). PMID: 23121972    Free PMC article.
Review.
A20 controls macrophage to elicit potent cytotoxic CD4(+) T cell response.
Lifeng Wang, Bangxing Hong, +3 authors, Xue F Huang.
PLoS One, 2012 Nov 13; 7(11). PMID: 23145026    Free PMC article.
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.
Jing Ni, Matthias Miller, +2 authors, Adelheid Cerwenka.
J Exp Med, 2012 Dec 05; 209(13). PMID: 23209317    Free PMC article.
Highly Cited.
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.
Marie-Clare St Rose, Roslyn A Taylor, +4 authors, Adam J Adler.
Immunol Cell Biol, 2013 Jan 09; 91(2). PMID: 23295363    Free PMC article.
ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.
J Ludovic Croxford, Melissa Li Fang Tang, +7 authors, Stephan Gasser.
Blood, 2013 Jan 26; 121(13). PMID: 23349395    Free PMC article.
Aire deficiency promotes TRP-1-specific immune rejection of melanoma.
Meng-Lei Zhu, Anil Nagavalli, Maureen A Su.
Cancer Res, 2013 Feb 02; 73(7). PMID: 23370329    Free PMC article.
Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation.
Adam J Adler, Anthony T Vella.
Oncoimmunology, 2013 Mar 14; 2(1). PMID: 23482891    Free PMC article.
Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.
Mark J Dobrzanski.
Front Oncol, 2013 Mar 28; 3. PMID: 23533029    Free PMC article.
Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.
Stephen R Goding, Kyle A Wilson, +7 authors, Paul Andrew Antony.
J Immunol, 2013 Mar 29; 190(9). PMID: 23536636    Free PMC article.
Highly Cited.
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin.
Michael A Curran, Theresa L Geiger, +5 authors, James P Allison.
J Exp Med, 2013 Apr 03; 210(4). PMID: 23547098    Free PMC article.
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells.
Pengfei Liu, Shubin Chen, +10 authors, Duanqing Pei.
PLoS One, 2013 Aug 08; 8(7). PMID: 23922758    Free PMC article.
Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.
Jennifer D Stone, David M Kranz.
Front Immunol, 2013 Aug 24; 4. PMID: 23970885    Free PMC article.
Changing T-cell enigma: cancer killing or cancer control?
Thomas Wieder, Heidi Braumüller, +2 authors, Martin Röcken.
Cell Cycle, 2013 Sep 10; 12(19). PMID: 24013429    Free PMC article.
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.
Sarah E Church, Shawn M Jensen, +2 authors, Bernard A Fox.
Eur J Immunol, 2013 Oct 12; 44(1). PMID: 24114780    Free PMC article.
Exchange of cytosolic content between T cells and tumor cells activates CD4 T cells and impedes cancer growth.
Matthias Hardtke-Wolenski, Lilli Kraus, +7 authors, Thorsten Lieke.
PLoS One, 2013 Nov 10; 8(10). PMID: 24205259    Free PMC article.
Human cell-based artificial antigen-presenting cells for cancer immunotherapy.
Marcus O Butler, Naoto Hirano.
Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329798    Free PMC article.
Review.
Establishment of HLA-DR4 transgenic mice for the identification of CD4+ T cell epitopes of tumor-associated antigens.
Junji Yatsuda, Atsushi Irie, +14 authors, Yasuharu Nishimura.
PLoS One, 2014 Jan 05; 8(12). PMID: 24386437    Free PMC article.
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.
Shigehisa Kitano, Takemasa Tsuji, +7 authors, Jedd D Wolchok.
Cancer Immunol Res, 2014 Jan 08; 1(4). PMID: 24396833    Free PMC article.
TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma.
Mohammad N Uddin, Yubin Zhang, +2 authors, Dorina Avram.
J Immunol, 2014 Jan 22; 192(4). PMID: 24446520    Free PMC article.
SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.
Rajesh K Sharma, Esma S Yolcu, Haval Shirwan.
Expert Rev Vaccines, 2014 Feb 14; 13(3). PMID: 24521311    Free PMC article.
Review.
Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.
Ping-Chih Ho, Katrina M Meeth, +3 authors, Susan M Kaech.
Cancer Res, 2014 Apr 17; 74(12). PMID: 24736544    Free PMC article.
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
Ole Audun Werner Haabeth, Anders Aune Tveita, +8 authors, Bjarne Bogen.
Front Immunol, 2014 May 02; 5. PMID: 24782871    Free PMC article.
Highly Cited. Review.
Th17 cells in cancer: the ultimate identity crisis.
Stefanie R Bailey, Michelle H Nelson, +3 authors, Chrystal M Paulos.
Front Immunol, 2014 Jul 06; 5. PMID: 24987392    Free PMC article.
Highly Cited. Review.
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.
Dong-Sup Chung, Hye-Jin Shin, Yong-Kil Hong.
J Immunol Res, 2014 Jul 11; 2014. PMID: 25009822    Free PMC article.
Review.
CD4 T cells specific for a latency-associated γ-herpesvirus epitope are polyfunctional and cytotoxic.
Michael L Freeman, Claire E Burkum, +11 authors, Marcia A Blackman.
J Immunol, 2014 Nov 08; 193(12). PMID: 25378595    Free PMC article.
Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells.
Xiaoyun Lu, Zhi-Chun Ding, +8 authors, Gang Zhou.
J Immunol, 2015 Jan 07; 194(4). PMID: 25560408    Free PMC article.
Breaking through the central tolerance ceiling to unleash anticancer immune responses.
Maureen A Su, Mark S Anderson.
Oncoimmunology, 2015 Jan 23; 3(8). PMID: 25610739    Free PMC article.
Metastatic melanoma cells evade immune detection by silencing STAT1.
JoDi Lynn Osborn, Susanna F Greer.
Int J Mol Sci, 2015 Feb 19; 16(2). PMID: 25690042    Free PMC article.
Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells.
Ivan Liadi, Harjeet Singh, +9 authors, Navin Varadarajan.
Cancer Immunol Res, 2015 Feb 26; 3(5). PMID: 25711538    Free PMC article.
IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age.
Hirotake Tsukamoto, Satoru Senju, +2 authors, Yasuharu Nishimura.
Nat Commun, 2015 Apr 08; 6. PMID: 25850032    Free PMC article.
An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
Matthew P Rausch, Karen Taraszka Hastings.
PLoS One, 2015 Apr 16; 10(4). PMID: 25875653    Free PMC article.
Limitations of bystander killing in Th1/M1 immune responses against a secreted tumor antigen.
Anders Aune Tveita, Ole Audun Haabeth, Bjarne Bogen.
Oncoimmunology, 2015 May 06; 3(9). PMID: 25941607    Free PMC article.
An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.
Neeraj Lal, Andrew D Beggs, Benjamin E Willcox, Gary W Middleton.
Oncoimmunology, 2015 May 08; 4(3). PMID: 25949894    Free PMC article.
Dendritic-tumor fusion cells derived heat shock protein70-peptide complex has enhanced immunogenicity.
Yunfei Zhang, Yong Zhang, +2 authors, Wen Luo.
PLoS One, 2015 May 12; 10(5). PMID: 25961716    Free PMC article.
Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.
Saleh Rachidi, Kristin Wallace, +3 authors, Zihai Li.
Head Neck, 2015 Jun 05; 38 Suppl 1. PMID: 26040762    Free PMC article.
EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.
Laura Pisapia, Pasquale Barba, +3 authors, Giovanna Del Pozzo.
Int J Oncol, 2015 Jun 18; 47(2). PMID: 26081906    Free PMC article.
Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.
Simone Kayser, Cristina Boβ, +11 authors, Tobias Feuchtinger.
Oncoimmunology, 2015 Jul 15; 4(5). PMID: 26155389    Free PMC article.
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine.
Jeanne Galaine, Christophe Borg, Yann Godet, Olivier Adotévi.
Vaccines (Basel), 2015 Sep 10; 3(3). PMID: 26350591    Free PMC article.
Review.
Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells.
Kyle A Wilson, Stephen R Goding, +2 authors, Paul Andrew Antony.
Oncoimmunology, 2015 Sep 26; 4(8). PMID: 26405570    Free PMC article.
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
Junko Matsuzaki, Takemasa Tsuji, +7 authors, Kunle Odunsi.
Sci Rep, 2015 Oct 09; 5. PMID: 26447332    Free PMC article.
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.
Thomas M Schmitt, Ingunn M Stromnes, Aude G Chapuis, Philip D Greenberg.
Clin Cancer Res, 2015 Oct 16; 21(23). PMID: 26463711    Free PMC article.
Review.
Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery.
Jianbin Wang, Joshua J DeClercq, +5 authors, Michael C Holmes.
Nucleic Acids Res, 2015 Nov 04; 44(3). PMID: 26527725    Free PMC article.
T-cell receptor gene therapy--ready to go viral?
Terhi Karpanen, Johanna Olweus.
Mol Oncol, 2015 Nov 10; 9(10). PMID: 26548533    Free PMC article.
Review.
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.
Payal Mittal, Marie-Clare St Rose, +4 authors, Adam J Adler.
J Immunol, 2015 Nov 13; 195(12). PMID: 26561553    Free PMC article.
Lineage re-commitment of CD4CD8αα intraepithelial lymphocytes in the gut.
Yunji Park, Sook-Jin Moon, Seung-Woo Lee.
BMB Rep, 2015 Nov 26; 49(1). PMID: 26592937    Free PMC article.
Review.
Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes.
Mei Zhang, Hallie Graor, Lu Yan, Julian Kim.
J Immunother, 2015 Dec 08; 39(1). PMID: 26641258    Free PMC article.
CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
Arata Takeuchi, Mohamed El Sherif Gadelhaq Badr, +11 authors, Takashi Saito.
J Exp Med, 2015 Dec 24; 213(1). PMID: 26694968    Free PMC article.
Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion.
Nicole Malandro, Sadna Budhu, +9 authors, Jedd D Wolchok.
Immunity, 2016 Jan 21; 44(1). PMID: 26789923    Free PMC article.
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
Kinga Majchrzak, Michelle H Nelson, +5 authors, Chrystal M Paulos.
Cancer Immunol Immunother, 2016 Jan 31; 65(3). PMID: 26825102    Free PMC article.
Review.
Tumour-specific CD4 T cells eradicate melanoma via indirect recognition of tumour-derived antigen.
Elena Shklovskaya, Alexandra M Terry, +5 authors, Barbara Fazekas de St. Groth.
Immunol Cell Biol, 2016 Feb 04; 94(6). PMID: 26837456
A role for pre-mNK cells in tumor progression.
Carolyn Rosinsky, Paul Andrew Antony.
J Immunother Cancer, 2016 Mar 17; 4. PMID: 26981246    Free PMC article.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Meng-Lei Zhu, Pearl Bakhru, +6 authors, Maureen A Su.
Nat Commun, 2016 Apr 14; 7. PMID: 27072778    Free PMC article.
Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity.
Thomas V Guy, Alexandra M Terry, +6 authors, Barbara Fazekas de St. Groth.
Oncotarget, 2016 Apr 29; 7(21). PMID: 27121060    Free PMC article.
Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma.
Hongwei Xue, Fuhuang Lin, +3 authors, Ludong Zhao.
PLoS One, 2016 May 03; 11(5). PMID: 27136203    Free PMC article.
Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.
Xin Yao, Yong-Chen Lu, +8 authors, Paul F Robbins.
J Immunother, 2016 May 11; 39(5). PMID: 27163739    Free PMC article.
An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs.
Masatoshi Hirayama, Yusuke Tomita, +16 authors, Yasuharu Nishimura.
Oncoimmunology, 2016 Jul 30; 5(6). PMID: 27471607    Free PMC article.
IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells.
Zhi-Chun Ding, Chufeng Liu, +10 authors, Gang Zhou.
Oncoimmunology, 2016 Jul 30; 5(6). PMID: 27471650    Free PMC article.
Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display.
Anders Tveita, Marte Fauskanger, Bjarne Bogen, Ole Audun Werner Haabeth.
Oncotarget, 2016 Sep 15; 7(41). PMID: 27626487    Free PMC article.
CD4+ T cell-mediated cytotoxicity eliminates primary tumor cells in metastatic melanoma through high MHC class II expression and can be enhanced by inhibitory receptor blockade.
Hongxia Yan, Xianglian Hou, +4 authors, Ruijie Zhu.
Tumour Biol, 2016 Oct 07;. PMID: 27709550
Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients.
Maggie L Diller, Ragini R Kudchadkar, +2 authors, Mandy L Ford.
J Immunother, 2016 Oct 16; 39(9). PMID: 27741090    Free PMC article.
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.
Adam J Adler, Payal Mittal, +3 authors, Anthony T Vella.
Immunotherapy, 2016 Dec 22; 9(1). PMID: 28000531    Free PMC article.
Review.
The distribution and function of human memory T cell subsets in lung cancer.
Si Yuan Sheng, Yong Gu, +3 authors, RongFu Wang.
Immunol Res, 2017 Jan 20; 65(3). PMID: 28101811    Free PMC article.
Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Matthew H Spitzer, Yaron Carmi, +10 authors, Edgar G Engleman.
Cell, 2017 Jan 24; 168(3). PMID: 28111070    Free PMC article.
Highly Cited.
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.
Nobutaka Hanagata.
Int J Nanomedicine, 2017 Feb 02; 12. PMID: 28144136    Free PMC article.
Review.
Fine-tuning the CAR spacer improves T-cell potency.
Norihiro Watanabe, Pradip Bajgain, +6 authors, Juan F Vera.
Oncoimmunology, 2017 Feb 10; 5(12). PMID: 28180032    Free PMC article.
Highly Cited.
Combination immunotherapy: a road map.
Patrick A Ott, F Stephen Hodi, +2 authors, Jedd D Wolchok.
J Immunother Cancer, 2017 Feb 28; 5. PMID: 28239469    Free PMC article.
Highly Cited. Review.
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function.
Arata Takeuchi, Takashi Saito.
Front Immunol, 2017 Mar 11; 8. PMID: 28280496    Free PMC article.
Highly Cited. Review.
Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis.
Daniel J Neitzke, Jacob S Bowers, +7 authors, Mark P Rubinstein.
Cancer Immunol Immunother, 2017 Mar 11; 66(6). PMID: 28280853    Free PMC article.
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion.
Jacob S Bowers, Michelle H Nelson, +6 authors, Chrystal M Paulos.
JCI Insight, 2017 Mar 16; 2(5). PMID: 28289713    Free PMC article.
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system.
Krishna Das, David Eisel, +5 authors, Stefan B Eichmüller.
PLoS One, 2017 Mar 17; 12(3). PMID: 28301575    Free PMC article.
The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.
Kun He, Ping Liu, Lisa X Xu.
Cell Death Dis, 2017 Mar 24; 8(3). PMID: 28333145    Free PMC article.
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.
Barbara Seliger, Matthias Kloor, Soldano Ferrone.
Oncoimmunology, 2017 Mar 28; 6(2). PMID: 28344859    Free PMC article.
Review.
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity.
Kinga Majchrzak, Michelle H Nelson, +9 authors, Chrystal M Paulos.
JCI Insight, 2017 Apr 20; 2(8). PMID: 28422756    Free PMC article.
B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment.
Giulia Chiaruttini, Silvia Mele, +4 authors, Sophia N Karagiannis.
Oncoimmunology, 2017 May 17; 6(4). PMID: 28507802    Free PMC article.
Review.
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells.
Caroline Boudousquie, Giovanna Bossi, +3 authors, Namir J Hassan.
Immunology, 2017 Jun 24; 152(3). PMID: 28640942    Free PMC article.
Resident memory T cells in the skin mediate durable immunity to melanoma.
Brian T Malik, Katelyn T Byrne, +9 authors, Mary Jo Turk.
Sci Immunol, 2017 Jul 25; 2(10). PMID: 28738020    Free PMC article.
Highly Cited.
Vaccines targeting helper T cells for cancer immunotherapy.
Marit Melssen, Craig L Slingluff.
Curr Opin Immunol, 2017 Jul 30; 47. PMID: 28755541    Free PMC article.
Review.
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
Yong-Chen Lu, Linda L Parker, +14 authors, Steven A Rosenberg.
J Clin Oncol, 2017 Aug 16; 35(29). PMID: 28809608    Free PMC article.
Highly Cited.
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
In Ah Park, Seong-Hye Hwang, +7 authors, Hee Jin Lee.
PLoS One, 2017 Aug 18; 12(8). PMID: 28817603    Free PMC article.
The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.
Howard Y Li, Maria McSharry, +8 authors, Raphael A Nemenoff.
Cancer Immunol Res, 2017 Aug 19; 5(9). PMID: 28819064    Free PMC article.
Most Do, but Some Do Not: CD4⁺CD25- T Cells, but Not CD4⁺CD25⁺ Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR).
Andreas A Hombach, Hinrich Abken.
Cancers (Basel), 2017 Aug 30; 9(9). PMID: 28850063    Free PMC article.
Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.
Tomohiro Tanaka, Satoshi Watanabe, +20 authors, Toshiaki Kikuchi.
PLoS One, 2017 Aug 31; 12(8). PMID: 28854279    Free PMC article.
Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.
David J Messenheimer, Shawn M Jensen, +6 authors, Bernard A Fox.
Clin Cancer Res, 2017 Sep 01; 23(20). PMID: 28855348    Free PMC article.
Highly Cited.
Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells.
Zhi-Chun Ding, Tsadik Habtetsion, +8 authors, Gang Zhou.
Sci Rep, 2017 Sep 25; 7(1). PMID: 28939858    Free PMC article.
Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF.
Andrea J Manrique-Rincón, Camila M Beraldo, Jessica M Toscaro, Marcio C Bajgelman.
Front Immunol, 2017 Oct 05; 8. PMID: 28974950    Free PMC article.
CD4 and CD8 T lymphocyte interplay in controlling tumor growth.
Dmitrij Ostroumov, Nora Fekete-Drimusz, +2 authors, Norman Woller.
Cell Mol Life Sci, 2017 Oct 17; 75(4). PMID: 29032503    Free PMC article.
Review.
Periodically Pulsed Immunotherapy in a Mathematical Model of Tumor, CD4+ T Cells, and Antitumor Cytokine Interactions.
Hsiu-Chuan Wei, Jui-Ling Yu, Chia-Yu Hsu.
Comput Math Methods Med, 2017 Dec 19; 2017. PMID: 29250133    Free PMC article.
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
Payal Mittal, Rebecca Abblett, +8 authors, Adam J Adler.
J Immunol, 2018 Jan 07; 200(4). PMID: 29305435    Free PMC article.
Citrullinated α-enolase is an effective target for anti-cancer immunity.
Katherine Cook, Ian Daniels, +6 authors, Victoria Brentville.
Oncoimmunology, 2018 Jan 09; 7(2). PMID: 29308319    Free PMC article.
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.
Il-Kyu Choi, Zhe Wang, +10 authors, Baochun Zhang.
Proc Natl Acad Sci U S A, 2018 Jan 10; 115(4). PMID: 29311309    Free PMC article.
Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.
Shinji Matsutani, Masatsune Shibutani, +5 authors, Masaichi Ohira.
Cancer Sci, 2018 Feb 22; 109(4). PMID: 29464828    Free PMC article.
17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.
Sandeep S Joshi, Shunlin Jiang, +4 authors, Thomas J Hornyak.
PLoS One, 2018 Feb 27; 13(2). PMID: 29481571    Free PMC article.
The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.
Yasmina Serroukh, Chunyan Gu-Trantien, +15 authors, Arnaud Marchant.
Elife, 2018 Mar 01; 7. PMID: 29488879    Free PMC article.
Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.
Masafumi Taniwaki, Mihoko Yoshida, +3 authors, Hiroto Kaneko.
Mediterr J Hematol Infect Dis, 2018 Mar 14; 10(1). PMID: 29531651    Free PMC article.
Review.
When worlds collide: Th17 and Treg cells in cancer and autoimmunity.
Hannah M Knochelmann, Connor J Dwyer, +4 authors, Chrystal M Paulos.
Cell Mol Immunol, 2018 Mar 23; 15(5). PMID: 29563615    Free PMC article.
Highly Cited. Review.
Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal cancer.
Shinji Matsutani, Masatsune Shibutani, +5 authors, Masaichi Ohira.
Oncotarget, 2018 Apr 11; 9(20). PMID: 29632635    Free PMC article.
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.
Dongrui Wang, Brenda Aguilar, +6 authors, Christine E Brown.
JCI Insight, 2018 May 18; 3(10). PMID: 29769444    Free PMC article.
Highly Cited.
Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity.
T N Sharapova, E A Romanova, L P Sashchenko, D V Yashin.
J Immunol Res, 2018 Jun 01; 2018. PMID: 29850628    Free PMC article.
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial.
Poulam M Patel, Christian H Ottensmeier, +15 authors, Lindy G Durrant.
Oncoimmunology, 2018 Jun 07; 7(6). PMID: 29872563    Free PMC article.
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies.
Hannah M Knochelmann, Aubrey S Smith, +3 authors, Chrystal M Paulos.
Front Immunol, 2018 Aug 25; 9. PMID: 30140266    Free PMC article.
Highly Cited. Review.
The Paradoxical Role of NKG2D in Cancer Immunity.
Sam Sheppard, Amir Ferry, Joana Guedes, Nadia Guerra.
Front Immunol, 2018 Aug 29; 9. PMID: 30150983    Free PMC article.
Review.
Synaptic Interactions in Germinal Centers.
Ilenia Papa, Carola G Vinuesa.
Front Immunol, 2018 Aug 29; 9. PMID: 30150988    Free PMC article.
Review.
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity.
Claudia Afferni, Carla Buccione, +5 authors, Giovanna Schiavoni.
Front Immunol, 2018 Nov 30; 9. PMID: 30483263    Free PMC article.
Review.
Functional Heterogeneity of CD4+ Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC.
Anna E Oja, Berber Piet, +8 authors, Pleun Hombrink.
Front Immunol, 2018 Dec 07; 9. PMID: 30505306    Free PMC article.
A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity.
Diana Rasoulouniriana, Nadine Santana-Magal, +11 authors, Yaron Carmi.
J Clin Invest, 2019 Aug 27; 129(10). PMID: 31449054    Free PMC article.
T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.
Preeti Sharma, Daniel T Harris, Jennifer D Stone, David M Kranz.
Cancer Immunol Res, 2019 Sep 25; 7(12). PMID: 31548259    Free PMC article.
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control.
Elena Tondini, Tsolere Arakelian, +7 authors, Ferry Ossendorp.
Oncoimmunology, 2019 Oct 28; 8(11). PMID: 31646082    Free PMC article.
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox.
Alessandro Allegra, Vanessa Innao, +4 authors, Sebastiano Gangemi.
Int J Mol Sci, 2019 Oct 28; 20(20). PMID: 31652497    Free PMC article.
Review.
Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians.
Kosuke Hashimoto, Tsukasa Kouno, +17 authors, Piero Carninci.
Proc Natl Acad Sci U S A, 2019 Nov 14; 116(48). PMID: 31719197    Free PMC article.
The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity.
Lixin Wang, Wenbin Wu, +7 authors, Shiguo Zhu.
Front Pharmacol, 2019 Nov 30; 10. PMID: 31780946    Free PMC article.
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.
Margaret L Axelrod, Rebecca S Cook, Douglas B Johnson, Justin M Balko.
Clin Cancer Res, 2018 Nov 23; 25(8). PMID: 30463850    Free PMC article.
Review.
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.
Pavlina Chuntova, Kira M Downey, +2 authors, Hideho Okada.
Front Immunol, 2019 Feb 12; 9. PMID: 30740109    Free PMC article.
Review.
Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.
Crystal Morales Del Valle, Joseph R Maxwell, +5 authors, Anthony T Vella.
Cell Rep, 2019 May 03; 27(5). PMID: 31042471    Free PMC article.
Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer.
Nithya Sivaram, Patrick A McLaughlin, +7 authors, Richard Z Lin.
J Clin Invest, 2019 May 22; 129(8). PMID: 31112530    Free PMC article.
IL22 drives cutaneous melanoma cell proliferation, migration and invasion through activation of miR-181/STAT3/AKT axis.
Yuanmin He, Yan Yang, +4 authors, Xia Xiong.
J Cancer, 2020 Mar 24; 11(9). PMID: 32201538    Free PMC article.
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation.
Teresa Preglej, Patricia Hamminger, +22 authors, Wilfried Ellmeier.
JCI Insight, 2020 Feb 28; 5(4). PMID: 32102981    Free PMC article.
Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype.
David Eisel, Krishna Das, +3 authors, Stefan B Eichmüller.
Front Immunol, 2019 Mar 12; 10. PMID: 30853959    Free PMC article.
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.
Marjolein Schluck, Roel Hammink, +2 authors, Jorieke Weiden.
Front Immunol, 2019 May 28; 10. PMID: 31130945    Free PMC article.
Review.
Combined Photosensitization and Vaccination Enable CD8 T-Cell Immunity and Tumor Suppression Independent of CD4 T-Cell Help.
Eleni Maria Varypataki, Fabio Hasler, +6 authors, Pål Johansen.
Front Immunol, 2019 Jul 25; 10. PMID: 31333674    Free PMC article.
Long-term surviving cancer patients as a source of therapeutic TCR.
Else Marit Inderberg, Sébastien Wälchli.
Cancer Immunol Immunother, 2020 Jan 10; 69(5). PMID: 31915853    Free PMC article.
Review.
From Superantigens to "Real" Viral Antigens.
Marcia A Blackman.
Viral Immunol, 2020 Apr 15; 33(3). PMID: 32286177    Free PMC article.
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.
Victoria A Brentville, Rachael L Metheringham, +11 authors, Lindy G Durrant.
J Immunother Cancer, 2020 Jun 21; 8(1). PMID: 32561639    Free PMC article.
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Matthew P Rausch, Lydia R Meador, +4 authors, K Taraszka Hastings.
J Immunol, 2020 Apr 10; 204(11). PMID: 32269095    Free PMC article.
Telomerase and CD4 T Cell Immunity in Cancer.
Magalie Dosset, Andrea Castro, Hannah Carter, Maurizio Zanetti.
Cancers (Basel), 2020 Jul 08; 12(6). PMID: 32630460    Free PMC article.
Review.
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells.
Anna Śledzińska, Maria Vila de Mucha, +19 authors, Sergio A Quezada.
Immunity, 2020 Jan 12; 52(1). PMID: 31924474    Free PMC article.
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy.
Lukas Amon, Lukas Hatscher, +2 authors, Christian H K Lehmann.
Pharmaceutics, 2020 Jul 18; 12(7). PMID: 32674488    Free PMC article.
Review.
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.
Joji Nagasaki, Yosuke Togashi, +10 authors, Hiroyoshi Nishikawa.
Blood Adv, 2020 Sep 02; 4(17). PMID: 32870971    Free PMC article.
CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells.
Ziqiang Zhu, Steven M Cuss, +5 authors, Arthur A Hurwitz.
J Immunol, 2015 Sep 01; 195(7). PMID: 26320256    Free PMC article.
Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
L Zhang, Z Yu, +4 authors, R A Morgan.
Gene Ther, 2012 Sep 14; 20(5). PMID: 22972494    Free PMC article.
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.
Eric Tran, Simon Turcotte, +10 authors, Steven A Rosenberg.
Science, 2014 May 09; 344(6184). PMID: 24812403    Free PMC article.
Highly Cited.
IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity.
Hidekazu Shirota, Dennis M Klinman, +3 authors, Chikashi Ishioka.
Cancer Immunol Res, 2016 Dec 07; 5(1). PMID: 27920023    Free PMC article.
Robust Production of Merkel Cell Polyomavirus Oncogene Specific T Cells From Healthy Donors for Adoptive Transfer.
Sarah I Davies, John Barrett, +3 authors, Isaac Brownell.
Front Immunol, 2020 Dec 29; 11. PMID: 33362774    Free PMC article.
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy.
Spencer E Brightman, Martin S Naradikian, Aaron M Miller, Stephen P Schoenberger.
J Leukoc Biol, 2020 Mar 15; 107(4). PMID: 32170883    Free PMC article.
Review.
The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function.
Yashwanth Subbannayya, Markus Haug, +5 authors, Richard K Kandasamy.
Int J Mol Sci, 2021 Jan 02; 22(1). PMID: 33383959    Free PMC article.
CD4+ T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade.
Jinfei Fu, Anze Yu, +4 authors, Bin He.
Am J Cancer Res, 2021 Jan 09; 10(12). PMID: 33414997    Free PMC article.
CD4 Inhibits Helper T Cell Activation at Lower Affinity Threshold for Full-Length T Cell Receptors Than Single Chain Signaling Constructs.
Deborah K Johnson, Wyatt Magoffin, +6 authors, K Scott Weber.
Front Immunol, 2021 Feb 06; 11. PMID: 33542711    Free PMC article.
Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.
Rong En Tay, Emma K Richardson, Han Chong Toh.
Cancer Gene Ther, 2020 May 28; 28(1-2). PMID: 32457487    Free PMC article.
Review.
Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms.
Jianyu Chen, Honghao Zhang, +4 authors, Yuhua Li.
Front Oncol, 2021 Feb 23; 10. PMID: 33614478    Free PMC article.
Review.
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.
Amélie Cachot, Mariia Bilous, +22 authors, Camilla Jandus.
Sci Adv, 2021 Feb 28; 7(9). PMID: 33637530    Free PMC article.
Default polyfunctional T helper 1 response to ample signal 1 alone.
Luca Danelli, Georgina Cornish, Julia Merkenschlager, George Kassiotis.
Cell Mol Immunol, 2020 Apr 22; 18(7). PMID: 32313208    Free PMC article.
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer.
Margaux Saillard, Mara Cenerenti, Pedro Romero, Camilla Jandus.
Vaccines (Basel), 2021 Jun 03; 9(5). PMID: 34064410    Free PMC article.
Review.
Persistent STAT5 activation reprograms the epigenetic landscape in CD4+ T cells to drive polyfunctionality and antitumor immunity.
Zhi-Chun Ding, Huidong Shi, +11 authors, Gang Zhou.
Sci Immunol, 2020 Nov 01; 5(52). PMID: 33127608    Free PMC article.
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.
Elena Shklovskaya, Helen Rizos.
Int J Mol Sci, 2021 Jul 03; 22(13). PMID: 34201655    Free PMC article.
Review.
Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy.
Elodie Renaude, Marie Kroemer, +4 authors, Olivier Adotévi.
Front Immunol, 2021 Jul 16; 12. PMID: 34262562    Free PMC article.
Review.
Double-edged effects of interferons on the regulation of cancer-immunity cycle.
Xiao Zhang, Song Wang, +5 authors, Xiaobo Li.
Oncoimmunology, 2021 Jul 16; 10(1). PMID: 34262796    Free PMC article.
Review.
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.
Alexander J Stephens, Nicola A Burgess-Brown, Shisong Jiang.
Front Immunol, 2021 Jul 20; 12. PMID: 34276688    Free PMC article.
Review.
Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
Cory J Knudson, Maria Férez, +5 authors, Luis J Sigal.
J Virol, 2021 Jul 15; 95(19). PMID: 34260270    Free PMC article.
Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4+ T Cells in the Central Region of pMMR CRC.
Jingwen Qi, Xiaoyan Liu, +14 authors, Wei Yang.
Front Oncol, 2021 Oct 12; 11. PMID: 34631551    Free PMC article.
Immunity beyond cancer cells: perspective from tumor tissue.
Shengyu Gao, Ting-Wei Hsu, Ming O Li.
Trends Cancer, 2021 Jul 27; 7(11). PMID: 34305041    Free PMC article.
Review.
Supplementation with Serum-Derived Extracellular Vesicles Reinforces Antitumor Immunity Induced by Cryo-Thermal Therapy.
Yinuo Cen, Yue Lou, +4 authors, Ping Liu.
Int J Mol Sci, 2021 Oct 24; 22(20). PMID: 34681680    Free PMC article.
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
Alexandra M Miggelbrink, Joshua D Jackson, +4 authors, Peter E Fecci.
Clin Cancer Res, 2021 Jun 16; 27(21). PMID: 34127507    Free PMC article.
Review.
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.
Eva-Maria Surmann, Anita Y Voigt, +5 authors, Matthias Kloor.
Cancer Immunol Immunother, 2014 Dec 03; 64(3). PMID: 25445815    Free PMC article.
Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.
Semir Beyaz, Charlie Chung, +30 authors, Ömer H Yilmaz.
Cell Stem Cell, 2021 Sep 17; 28(11). PMID: 34529935    Free PMC article.
Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma.
Kimberly Loo, James W Smithy, Michael A Postow, Allison Betof Warner.
Front Immunol, 2022 Jan 29; 12. PMID: 35087529    Free PMC article.
Review.
Identification of neoantigens for individualized therapeutic cancer vaccines.
Franziska Lang, Barbara Schrörs, +2 authors, Ugur Sahin.
Nat Rev Drug Discov, 2022 Feb 03; 21(4). PMID: 35105974    Free PMC article.
Review.
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox.
David Y Oh, Lawrence Fong.
Immunity, 2021 Dec 16; 54(12). PMID: 34910940    Free PMC article.
Review.
A T-cell independent universal cellular therapy strategy through antigen depletion.
Dan Li, Wenbing Wang, +6 authors, Han Liu.
Theranostics, 2022 Feb 15; 12(3). PMID: 35154479    Free PMC article.
Epigenetics of Dendritic Cells in Tumor Immunology.
Gerard Godoy-Tena, Esteban Ballestar.
Cancers (Basel), 2022 Mar 11; 14(5). PMID: 35267487    Free PMC article.
Review.
Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens.
Selma Bekri, Reunet Rodney-Sandy, +5 authors, Hearn Jay Cho.
J Immunother Cancer, 2022 Feb 23; 10(2). PMID: 35190376    Free PMC article.
Messenger RNA vaccines for cancer immunotherapy: progress promotes promise.
Amanda L Huff, Elizabeth M Jaffee, Neeha Zaidi.
J Clin Invest, 2022 Mar 16; 132(6). PMID: 35289317    Free PMC article.
Review.
High-throughput single-сell sequencing in cancer research.
Qingzhu Jia, Han Chu, +2 authors, Bo Zhu.
Signal Transduct Target Ther, 2022 May 04; 7(1). PMID: 35504878    Free PMC article.
Review.
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Rodrigo Nalio Ramos, Caroline Tosch, +20 authors, Karola Rittner.
Clin Transl Immunology, 2022 May 17; 11(5). PMID: 35573979    Free PMC article.